相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Stromal PD-1+ tumor-associated macrophages predict poor prognosis in lung adenocarcinoma
Lu Chen et al.
HUMAN PATHOLOGY (2020)
Association of PD-L1, PD-L2, and Immune Response Markers in Matched Renal Clear Cell Carcinoma Primary and Metastatic Tissue Specimens
Arnab Basu et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2019)
Expression of lymphocyte-activating gene 3 and T-cell immunoreceptor with immunoglobulin and ITIM domains in cutaneous melanoma and their correlation with programmed cell death 1 expression in tumor-infiltrating lymphocytes
Woo Jin Lee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Prognostic value of tumor-associated macrophages in pancreatic cancer: a meta-analysis
Min Yu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Prognostic significance of CD68+ and CD163+ tumor associated macrophages in head and neck squamous cell carcinoma: A systematic review and meta-analysis
Giuseppe Troiano et al.
ORAL ONCOLOGY (2019)
Macrophage-Mediated Subversion of Anti-Tumour Immunity
Valeria Quaranta et al.
CELLS (2019)
Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression
Anders Etzerodt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Prognostic significance of CD163 expression and its correlation with cyclooxygenase-2 and vascular endothelial growth factor expression in cutaneous melanoma
Woo J. Lee et al.
MELANOMA RESEARCH (2019)
Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond
Jeffrey E. Gershenwald et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment
Hirotake Tsukamoto et al.
CANCER RESEARCH (2018)
Clinicopathological significance of tumor-infiltrating lymphocytes and programmed death-1 expression in cutaneous melanoma: a comparative study on clinical subtypes
Woo J. Lee et al.
MELANOMA RESEARCH (2018)
Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases
Pooja Dhupkar et al.
CANCER MEDICINE (2018)
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, efficacy, and Limitations
Judith A. Seidel et al.
FRONTIERS IN ONCOLOGY (2018)
Targeting Macrophages in Cancer: From Bench to Bedside
Ashleigh R. Poh et al.
FRONTIERS IN ONCOLOGY (2018)
PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
Ramon Cantero-Cid et al.
BMC CANCER (2018)
Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma
Taku Fujimura et al.
FRONTIERS IN ONCOLOGY (2018)
PD-1 and its ligands are important immune checkpoints in cancer
Yinan Dong et al.
ONCOTARGET (2017)
Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis
Xia Yuan et al.
GYNECOLOGIC ONCOLOGY (2017)
Transcription Factor IRF4 Promotes CD8+ T Cell Exhaustion and Limits the Development of Memory-like T Cells during Chronic Infection
Kevin Man et al.
IMMUNITY (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature
Xixi Zhao et al.
ONCOTARGET (2017)
The Prognostic and Clinicopathological Significance of Tumor-Associated Macrophages in Patients with Gastric Cancer: A Meta-Analysis
Songcheng Yin et al.
PLOS ONE (2017)
Lymphocyte-activation gene-3, an important immune checkpoint in cancer
Yayi He et al.
CANCER SCIENCE (2016)
Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
Anna-Maria Georgoudaki et al.
CELL REPORTS (2016)
LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma
Wei-Wei Deng et al.
ONCOIMMUNOLOGY (2016)
Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression
Ang Yuan et al.
SCIENTIFIC REPORTS (2015)
Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
Brian Ruffell et al.
CANCER CELL (2014)
PD-1+ immune cell infiltration inversely correlates with survival of operable breast cancer patients
Shenyou Sun et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes/macrophages duringchronic hepatitis C virus infection
Cheng J. Ma et al.
IMMUNOLOGY (2011)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T Cells
Joseph F. Grosso et al.
JOURNAL OF IMMUNOLOGY (2009)
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Shawn D. Blackburn et al.
NATURE IMMUNOLOGY (2009)
分享论文
